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Case Report
A Rare Diagnosis of Strongyloides stercoralis in the
Pleural Cavity
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Description

Strongyloides stercoralis is a soil-transmitted helminth that causes strongyloidiasis, a
chronic parasitic infection in humans. S. stercoralis is one of several worm species that cause
soil-transmitted helminthiasis, a neglected tropical disease. Herein, we discuss a 78-year-old
female residing in a nursing home presenting with abdominal pain and shortness of breath.
During a thoracentesis, physicians found multiple rhabditoid larvae consistent with S. stercoralis. However, before the procedure, a serial assessment of stool sample was performed
and failed to demonstrate a parasitic infestation. Many of those infected with S. stercoralis
are asymptomatic. Lack of symptoms and low sensitivity in traditional parasitological testing hampers and delays the diagnosis of strongyloidiasis. This case serves as a reminder to
consider helminthic disease in the differential diagnosis.
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Introduction

Strongyloides stercoralis is a soil-transmitted
helminth that causes strongyloidiasis, a chronic
parasitic infection in humans. Strongyloidiasis
is endemic in tropical and subtropical regions
and areas with poor hygienic conditions.1 There
are high infection rates among underserved
populations, where prevalence rates can reach
75% in refugee and immigrant populations.2 An
estimated 30–100 million people are infected
with S. stercoralis worldwide; however, this
number may be understated as S. stercoralis
is frequently underdiagnosed because many
infections occur asymptomatically and diagnostic tests are not sufficiently sensitive.1,3 For
instance, using conventional techniques, a single stool examination failed to detect larvae in
up to 70% of the cases.4 Emad described a case
study of a 61-year-old man with diabetes mellitus who happened to have filariform larvae of
S. stercoralis in samples of his bronchial washings. Duodenal aspiration failed to yield ova
or parasites, and culture examination revealed
no bacteria, fungi or parasites.5 Alternative
tests such as serology and polymerase chain

reaction can be more efficient in detecting this
type of infection due to increased sensitivity.6,7
Notwithstanding, S. stercoralis can appear in a
non-endemic area where diagnostic tests are
not of great sensitivity.

Case Description

A 78-year-old woman presented to the emergency department complaining of abdominal
discomfort and shortness of breath. The patient had experienced progressively worsening
abdominal pain, nausea, vomiting, dysuria and
constipation two months before the admission. Her past medical history was significant
for immune thrombocytopenic purpura (ITP),
hypertension, diabetes mellitus, hyperlipidemia,
gastroesophageal reflux disease, diverticulosis
and an abdominal aortic aneurysm. The surgical history included splenectomy, hystero-oophorectomy and resection of a jaw tumor. The
patient was a former smoker who resided in a
nursing home.
Over the past two months, the patient was
tested for abdominal pain that yielded nega-
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tive results for human immunodeficiency virus
(HIV) and human T-lymphotropic virus 1 (HTLV1). A serial assessment of a stool sample was
performed for a possible small bowel infection
and failed to demonstrate the presence of a
parasitic infection. She was diagnosed with enteritis and small bowel infection and was treated with vancomycin via a peripherally inserted
central line at a skilled nursing facility.
The initial hospital presentation showed diminished bilateral breath sounds and significant
leukocytosis (15 x109/L). Computerized tomography of the abdomen and pelvis without contrast showed a small bowel obstruction related
to the distal jejunum/proximal ileum, diverticular disease and a 1.5 cm pleural-based nodule
located in the right lower lobe, possibly a granuloma. The patient developed a persistent right
pneumothorax and bilateral pleural effusion
later and subsequently underwent a thoracentesis. On cytology evaluation of pleural fluid,
multiple rhabditoid larvae with a short buccal
canal and prominent genital primordium/spike
in an acute inflammatory background were
consistent with S. stercoralis. (Figures 1 and
2) Once the helminth was identified, a subsequent stool test was performed and returned
positive for S. stercoralis.
The patient was treated with ivermectin;

Figure 1. Filariform larvae found in pleural fluid.
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however, two weeks after treatment, a follow-up stool exam confirmed the infestation
was still present. Therefore, the patient was
given two courses of albendazole for ten days.
Three weeks after the second round of treatment, computerized tomography of the chest
showed a decrease in the pleural-based nodule's size to less than 1 cm. The nodule probably represented reactivity and not granuloma.
Biopsies were not performed based on this result. Two months later, the patient was entirely
asymptomatic with a negative chest x-ray.

Discussion

S. stercoralis is one of several worm species
that cause soil-transmitted helminthiasis
(STH), a neglected tropical disease. Approximately 1.5 billion people are infected with STH,
with the majority in sub-Saharan Africa, the
Americas, China and East Asia.8 Individuals are
classically infected by S. stercoralis through
contact with soil that has been contaminated
with free-living larvae. Unlike other soil-transmitted helminths, S. stercoralis is unique because it can complete an entire life cycle within
a single individual, allowing for autoinfection.2,9
Its ability to establish a cycle of repeated endogenous reinfection within the host, coupled
with its typical asymptomatic nature, results
in a chronic infection that can last for several
decades.9
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Figure 2. Filariform larvae with marked acute inflammation.
Even though many of those infected with S.
stercoralis are asymptomatic, the disease can
be characterized by, but not limited to, abdominal pain, episodes of diarrhea and constipation,
chronic bronchitis, heartburn, pruritus and kidney problems. According to a 2013 meta-analysis of case-controlled studies by Schär et al.,
high infection prevalence rates of S. stercoralis
occur in the following high-risk groups: HIV/
AIDS, HTLV-1, alcohol addiction, diarrhea,
malignancy and immune-compromising conditions.2 Additionally, in immunosuppression
cases, S. stercoralis can cause hyperinfection
in its host where it can transport gut bacteria
into the blood, which can subsequently cause
pyogenic meningitis and sepsis.7 In our case,
the skilled nursing facility patient had a history
of an auto-immune disease (ITP), diabetes and
splenectomy, all of which made her more susceptible to systemic S. stercoralis infestation.
Immunosuppressed and elderly patients are
more likely to manifest the infestation.
Strongyloidiasis can be diagnosed through
various modalities, including a sputum culture,
duodenal aspiration, a blood antigen test and
most commonly by stool samples for ova and
parasites. The patient's initial stool sample
failed to demonstrate the presence of parasitic
infection, but subsequent samples were able
to detect larvae. This variability in a strongy-

loidiasis diagnosis occurs because the larval
output is irregular and the parasite load is low,
where there are less than 25 larvae per gram of
stool in more than two-thirds of strongyloidiasis cases.10 In addition to low parasite load and
variable output, gastrointestinal symptoms, as
seen in this patient, complicate a strongyloidiasis diagnosis.
The authors could find only one article that
illustrates an S. stercoralis infestation in the
pleural cavity. 5 However, additional infestations caused by other helminths in the pleural
cavity have been reported in the literature.
Farahmand and Yadollahi describe a case of a
14-year-old patient with a hydatidosis infestation. The patient presented with decreased
breath sounds on the left side, normal white
cells, a hydropneumothorax on the left side and
two pulmonary hydatid cysts. One of the cysts
drained to the left pleural cavity.11 The patient
was treated surgically and received albendazole. The patient was a shepherd who commonly was in close contact with mammals who
were hosts for the larvae that cause hydatid
disease.
Treatment for strongyloidiasis involves eliminating the organisms to prevent autoinfection
that may lead to hyperinfection, given this
helminth's unique life cycle. Ivermectin belongs
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to a group of drugs known as antihelmintic and
is the first-line therapy to treat strongyloidiasis. Patients treated with ivermectin should
receive follow-up stool tests to verify infection
eradication.12 Albendazole and thiabendazole
are also used as treatment. An analysis by
Henriquez-Camacho et al. involving 1,147 participants from 1994 to 2011 in several continents
concluded ivermectin results in more people
cured than albendazole. In other trials where
ivermectin with thiabendazole was used, there
are more adverse events with thiabendazole,
though the parasitological cure was similar.13
Although Strongyloides stercoralis infestation of the pleura is rare, this case serves as a
reminder to consider helminthic disease in the
differential diagnosis.
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